Cytoreductive Surgery and Hyperthermic Peritoneal Chemotherapy in Appendiceal and Colorectal Cancer: Outcomes and Survival.
Teresa Moreno DjadouKeat Seong PohShlomo YellinekHana FayazzadehKevin El-HayekConrad H SimpfendorferGiovanna DaSilvaSteven D WexnerPublished in: The American surgeon (2023)
Cytoreductive surgery/HIPEC for colorectal and appendiceal neoplasms has low mortality and high completeness of cytoreduction score. Preoperative chemotherapy, primary tumor perforation, and postoperative bleeding are adverse risk factors for survival.
Keyphrases
- minimally invasive
- coronary artery bypass
- low grade
- patients undergoing
- locally advanced
- free survival
- surgical site infection
- metastatic renal cell carcinoma
- atrial fibrillation
- type diabetes
- cardiovascular events
- metabolic syndrome
- acute coronary syndrome
- insulin resistance
- chemotherapy induced
- squamous cell carcinoma
- skeletal muscle
- cardiovascular disease
- electronic health record